Indication-specific Drug Pricing - Simple in Theory, Complex in Reality.

Varying drug prices by indication could be an important value-based strategy in oncology, where multiple indications are becoming the rule. But will administrative costs offset any benefit? And legal and regulatory obstacles could get in the way.